CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Shares, $0.0001 par value per share
Symbol
CTOR on Nasdaq
Shares outstanding
84,787,696
Price per share
$1.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
8,357,159
Total reported value
$16,966,429
% of total 13F portfolios
0%
Share change
+8,129,667
Value change
+$16,255,712
Number of holders
16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Citius Pharmaceuticals, Inc. 78% -1.5% $79,920,034 66,049,615 0% Citius Pharmaceuticals, Inc. 10 Dec 2025
ARMISTICE CAPITAL, LLC 9.8% $15,582,099 7,675,911 Armistice Capital, LLC 30 Sep 2025

As of 30 Sep 2025, 16 institutional investors reported holding 8,357,159 shares of CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR). This represents 9.9% of the company’s total 84,787,696 outstanding shares.

Institutional Holders of CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,500 $1,500 +$1,500 $1.00 1
2025 Q3 8,357,159 $16,966,429 +$16,255,712 $2.03 16
2025 Q2 227,492 $989,589 +$573,842 $4.35 7
2025 Q1 105,008 $97,657 -$115,519 $0.93 6
2024 Q4 200,884 $230,191 +$180,602 $1.15 11
2024 Q3 41,238 $57,016 +$57,016 $1.39 7